| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024685 |
| Receipt No. | R000025929 |
| Official scientific title of the study | Efficacy of daiobotampito in the treatment of acute diverticulitis of colon: a single-center open-label randomized controlled trial |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2017/04/05 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Efficacy of daiobotampito in the treatment of acute diverticulitis of colon: a single-center open-label randomized controlled trial | |
| Title of the study (Brief title) | Trial about efficacy of daiobotampito in the treatment of acute diverticulitis | |
| Region |
|
|
| Condition | |||
| Condition | diverticulitis of colon | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Evaluation of efficacy of daiobotampito in the treatment of diverticulitis |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Visual analogue scale (VAS) of abdominal pain on day 3 |
| Key secondary outcomes | VAS of abdominal pain other than day 3
Day on which VAS of pain becomes equal to or less than 50 mm Frequency of stool Frequency of ingravescence of diverticulitis, which patients need operation Frequency of adverse event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients are treated with fasting, antibacterial agents, and 7.5g per day of daiobotampito extract (Tsumura co.) for 10 days or not. | |
| Interventions/Control_2 | Patients are treated with fasting, antibacterial agents. They are not treated with daiobotampito extract. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with diverticulitis who have strong pain (VAS > 50mm) | |||
| Key exclusion criteria | High probability to perforate.
Diarrhea or soft stool. Chronic appetite loss, abdominal pain or diarrhea. Too friable. Insulin use. Immuno-compromised host. Pregnant or puerperal. Kidney disease (eGFR < 20 ml/min/1.73m^2). Allergy to daiobotampito. Experience to join in this trial before. Doctor's diagnosis as inappropriate. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Nakazawa, Atsushi |
| Organization | Tokyo Saiseikai Central Hospital |
| Division name | Gastrointestinal Medcine |
| Address | Mita 1-4-17, Minato-ku, Tokyo, Japan 108-0073 |
| TEL | 03-3451-8211 |
| anakaza@b-star.jp | |
| Public contact | |
| Name of contact person | Koike, Hiroshi |
| Organization | Tokyo Saiseikai Central Hospital |
| Division name | General Internal Medcine |
| Address | Mita 1-4-17, Minato-ku, Tokyo, Japan 108-0073 |
| TEL | 03-3451-8211 |
| Homepage URL | |
| koike-h@umin.ac.jp | |
| Sponsor | |
| Institute | Gastrointestinal Medcine, Tokyo Saiseikai Central Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Keio University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Center for Kampo Medicine, Keio University School of Medicine |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025929 |